Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast cancer liver metastasis: current and future treatment approaches
Narmeen S Rashid, Jacqueline M. Grible, Charles V. Clevenger, et al.
Clinical & Experimental Metastasis (2021) Vol. 38, Iss. 3, pp. 263-277
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study
Li Chen, Qiang Liu, Chunlei Tan, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 75-94
Open Access | Times Cited: 2
A Novel Method for the Early Detection of Single Circulating, Metastatic and Self-Seeding Cancer Cells in Orthotopic Breast Cancer Mouse Models
Muhammad Murad, Yanjiang Chen, Josie Iaria, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1166-1166
Open Access | Times Cited: 2
LPCAT1 is transcriptionally regulated by FOXA1 to promote breast cancer progression and paclitaxel resistance
Huayi Zhang, Yaqin Zheng
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 6
Functional transcriptional signatures for tumor-type-agnostic phenotype prediction
Corey Weistuch, Kevin A. Murgas, Jiening Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database
Yajie Wang, Yiran Liang, Fangzhou Ye, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18597-18610
Open Access | Times Cited: 5
RNA nanomedicine in liver diseases
Anita K. Bakrania, Yulin Mo, Gang Zheng, et al.
Hepatology (2023)
Closed Access | Times Cited: 5
Euphorbia factor L1 suppresses breast cancer liver metastasis via DDR1-mediated immune infiltration
Dongjing Jiang, XiaoQin Gao, Rulan Tan, et al.
Aging (2023) Vol. 15, Iss. 17, pp. 9217-9229
Open Access | Times Cited: 4
Deciphering Breast Cancer Metastasis Cascade: A Systems Biology Approach Integrating Transcriptome and Interactome Insights for Target Discovery
Bikashita Kalita, Mohane Selvaraj Coumar
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 3, pp. 148-161
Closed Access | Times Cited: 1
Integrated Bioinformatics Analysis for the Screening of Hub Genes in Breast Cancer Metastasis Recurrence at Liver
Tyler Kwok, Y. Suneetha, Kumaraswamy Naidu Chitrala
(2024)
Open Access | Times Cited: 1
Identification of Genes Crucial for Biological Processes in Breast Cancer Liver Metastasis Relapse
Tyler Kwok, Y. Suneetha, Kumaraswamy Naidu Chitrala
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5439-5439
Open Access | Times Cited: 1
Concise review: breast cancer stems cells and their role in metastases
Mohammad Kamalabadi‐Farahani, Mohammad Farjadmehr, Amir Atashi, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Leveraging preclinical models of metastatic breast cancer
Diego A. Pedroza, Yang Gao, Xiang H.-F. Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189163-189163
Closed Access | Times Cited: 1
Tumor-on-chip platforms for breast cancer continuum concept modeling
Anca-Narcisa Neagu, Danielle Whitham, Pathea Bruno, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression
Jianlong Wang, Bin Liu, Jiewei Cao, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 1973-1986
Open Access | Times Cited: 6
Integrated bioinformatic analysis to understand the association between phthalate exposure and breast cancer progression
Nadeem Khan G, Sangavi Eswaran, Divya Adiga, et al.
Toxicology and Applied Pharmacology (2022) Vol. 457, pp. 116296-116296
Closed Access | Times Cited: 6
Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases
Sophia Leduc, Maxim De Schepper, François Richard, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population‐based study in patients with breast cancer
Yue Chai, Yujie Chen, Jiaxuan Liu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 27, pp. 2793-2803
Open Access | Times Cited: 2
The tendency of segmental distribution of hepatic metastasis according to couinaud classification: a comparison of portal versus systemic route of metastatis due to primary colorectal and breast tumors
Dawar Khan, Ayimen Khalid Khan, Sarim Dawar Khan, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 4806-4810
Open Access | Times Cited: 2
Multiple breast cancer liver metastases response to macrophage‐delivered nanotherapy evaluated via a 3D continuum model
Dylan A. Goodin, Eric Chau, Anjana Tiwari, et al.
Immunology (2022) Vol. 169, Iss. 2, pp. 132-140
Open Access | Times Cited: 4
Increased RUNX1 mutations in breast cancer disease progression
Nur Syamimi Ariffin
Pathology - Research and Practice (2024) Vol. 254, pp. 155076-155076
Closed Access
Dialyl-sulfide with chalcone prevent breast cancer prohibiting SULT1E1 malregulations and oxidant-stress induced HIF1a-MMPs induction
Aarifa Nazmeen, Sayantani Maiti, Smarajit Maiti
Research Square (Research Square) (2024)
Open Access
PDGFR-targeted nanovesicles for restraining breast cancer hepatic metastasis via hepatic stellate cell regression and NK cell activation
Mengjie Kong, Yan Peng, Yujie Miao, et al.
Materials Today (2024) Vol. 79, pp. 1-15
Closed Access
Dialyl-sulfide with trans-chalcone prevent breast cancer prohibiting SULT1E1 malregulations and oxidant-stress induced HIF1a-MMPs induction
Aarifa Nazmeen, Sayantani Maiti, Smarajit Maiti
Genes & Cancer (2024) Vol. 15, pp. 41-59
Open Access
Does Hepatic Metastasectomy for Breast Cancer Oligo-Metastasis to the Liver Offer Survival Advantage? Systematic Review and Meta-Analysis
Ibrahım Umar Garzali, Abdurrahman Abba Sheshe, Ibrahim Eneye Suleiman, et al.
Journal of West African College of Surgeons (2024) Vol. 15, Iss. 2, pp. 129-135
Closed Access
Metastatic Breast Cancer mHealth App to Promote Patient-Provider Communication: Protocol for a Usability and Satisfaction Study (Preprint)
Thaís Fávero Alves, Kaitlyn Crosby, Ronnie D. Horner, et al.
(2024)
Closed Access

Scroll to top